US EditionOvarian cancer immunotherapy reactivates immune cells: Study
Summary by rarecancernews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Ovarian cancer immunotherapy reactivates immune cells: Study
An experimental immunotherapy known as MOv18 IgE showed promise in overcoming the immune suppression caused by ovarian cancer cells, potentially enabling the immune system to mount a stronger attack against tumors, a study found. Preliminary evidence from animal models and an early clinical trial have shown the therapy can help promote an immune response against cancer cells. Now, researchers investigated how MOv18 IgE interacts with the immune …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
